Received Sep 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLUZONE) | SANOFI PASTEUR | UNK | UT8852JA | OT / LA |
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | UNK | — | OT |
accidentally administered with FLUZONE NP twice instead of Prevnar20 with no reported adverse event; accidentally administered with FLUZONE NP twice instead of Prevnar20 with no reported adverse event; Initial information received on 25-Sep-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 56 years old female patient who accidentally administered with influenza USP trival A-B subvirion NO preservative vaccine [fluzone] twice instead of pneumococcal vaccine conj 20V (CRM197) [Prevnar 20] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 25-Sep-2025, the patient accidentally received 0.5 ml of suspect influenza USP trival A-B subvirion NO preservative vaccine Suspension for injection of standard strength, frequency once with lot UT8852JA and expiry date 30-JUN-2026 via intramuscular route in the left deltoid for Influenza twice instead of prevnar20 with no reported adverse event (extra dose administered) (wrong product administered) (Latency same day). Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.